EI
ALNY icon

Ethic Inc’s Alnylam Pharmaceuticals ALNY Stock Holding History

Ethic Inc’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56M Buy
5,172
+1,303
+34% +$393K 0.02% 579
2026
Q1 		$1.28M Buy
3,869
+651
+20% +$222K 0.02% 585
2025
Q4 		$1.28M Buy
3,218
+1,034
+47% +$458K 0.02% 569
2025
Q3 		$996K Buy
2,184
+8
+0.4% +$3.26K 0.02% 637
2025
Q2 		$703K Buy
2,176
+133
+7% +$36.8K 0.01% 720
2025
Q1 		$523K Sell
2,043
-2,843
-58% -$731K 0.01% 775
2024
Q4 		$1.15M Buy
4,886
+910
+23% +$239K 0.02% 555
2024
Q3 		$594K Buy
3,976
+449
+13% +$117K 0.02% 723
2024
Q2 		$857K Sell
3,527
-449
-11% -$70.9K 0.02% 612
2024
Q1 		$594K Sell
3,976
-33
-0.8% -$5.5K 0.02% 721
2023
Q4 		$767K Buy
4,009
+337
+9% +$57.4K 0.02% 615
2023
Q3 		$650K Buy
3,672
+1,699
+86% +$324K 0.02% 596
2023
Q2 		$375K Buy
1,973
+455
+30% +$90.2K 0.01% 734
2023
Q1 		$304K Sell
1,518
-391
-20% -$82.2K 0.01% 785
2022
Q4 		$454K Buy
1,909
+217
+13% +$46.3K 0.02% 602
2022
Q3 		$339K Buy
1,692
+172
+11% +$32.8K 0.02% 605
2022
Q2 		$222K Buy
+1,520
New +$216K 0.02% 694
2021
Q4 		– Sell
-1,122
Closed -$212K – 665
2021
Q3 		$212K Buy
+1,122
New +$210K 0.02% 568

Other funds holding ALNY

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
FAF
Fjarde Ap-fonden Stockholm, Sweden $20.9B AUM 36.93% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Ethic Inc's ALNY Position: Q2 2026 in Review

Ethic Inc increased its Alnylam Pharmaceuticals (ALNY) stake by 34% in Q2 2026, buying an estimated $393K and bringing the position to 5,172 shares worth $1.56M. The position accounts for 0.02% of the portfolio, ranked #579.

Ethic Inc first reported a position in ALNY in Q3 2021 and has held it in 18 quarters since. 211 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Ethic Inc held 5,172 shares of Alnylam Pharmaceuticals worth $1.56M as of Q2 2026.
  • Ethic Inc bought 1,303 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $393K.
  • Alnylam Pharmaceuticals made up 0.02% of Ethic Inc's portfolio in Q2 2026, its #579 holding.
  • Ethic Inc first reported a position in Alnylam Pharmaceuticals in Q3 2021 and has held it in 18 quarters since.
  • 211 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.